Список проголосовавших за комментарий " <table class="BriefingDataTable" border="0" cellspacing="0" cellpadding="0"><tr> <td class="tickerColumn"> </td> <td class="articleColumn">Conatus Pharma target raised to $9 at Stifel (4.91)Stifel raises their CNAT tgt to $9 from $7 as they believe the recent Novartis (<strong>NVS</strong>) collaboration provides a floor in CNAT shares as the company works through what should be an admittedly quiet FY17 until numerous P2b data catalysts related to the ENCORE development program begin to materialize in FY18.</td> </tr></table>"